APA (7th ed.) Citation

A, I., N, A., I, M., L, C., D, M., B, L., . . . CI, R. (2024). Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 175, 116725. https://doi.org/10.1016/j.biopha.2024.116725

Chicago Style (17th ed.) Citation

A, Infante, et al. "Galunisertib Downregulates Mutant Type I Collagen Expression and Promotes MSCs Osteogenesis in Pediatric Osteogenesis Imperfecta." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 175 (2024): 116725. https://doi.org/10.1016/j.biopha.2024.116725.

MLA (9th ed.) Citation

A, Infante, et al. "Galunisertib Downregulates Mutant Type I Collagen Expression and Promotes MSCs Osteogenesis in Pediatric Osteogenesis Imperfecta." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 175, 2024, p. 116725, https://doi.org/10.1016/j.biopha.2024.116725.